MUMBAI, India, Jan. 9 -- Intellectual Property India has published a patent application (202517077883 A) filed by Translational Health Science And Technology Institute; and Rajiv Gandhi Centre For Biotechnology, Faridabad, Haryana, on Aug. 15, 2025, for 'monoclonal antibodies against nipah virus.'
Inventor(s) include Bhattacharya, Jayanta; Deshpande, Suprit; Shrivas, Shweta; and Kumar, Naresh.
The application for the patent was published on Dec. 12, under issue no. 50/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to an engineered monoclonal antibody having fragments of heavy chain (HC) and light chain (LC) selected from SEQ ID No. 1, 2, 3, 4, 5, 6, 7, 8, 9 10, 11, 12, 13, 14 and 15 or a combination thereof for interacting and neutralizing Nipah virus as well as Hendra virus isolate. The present invention also discloses the method of production of monoclonal antibodies and its use thereof."
Disclaimer: Curated by HT Syndication.
